Detalhe da pesquisa
1.
B cells and tertiary lymphoid structures promote immunotherapy response.
Nature
; 577(7791): 549-555, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31942075
2.
Immunomodulatory impact of α-fetoprotein.
Trends Immunol
; 43(6): 438-448, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550875
3.
The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021.
J Transl Med
; 20(1): 179, 2022 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35449104
4.
The future of cancer immunotherapy for brain tumors: a collaborative workshop.
J Transl Med
; 20(1): 236, 2022 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35606815
5.
Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males.
J Transl Med
; 20(1): 253, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659704
6.
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors.
J Transl Med
; 20(1): 331, 2022 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879777
7.
The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020.
J Transl Med
; 19(1): 144, 2021 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827609
8.
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy).
J Transl Med
; 19(1): 13, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33407605
9.
Accelerating the development of innovative cellular therapy products for the treatment of cancer.
Cytotherapy
; 22(5): 239-246, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32199724
10.
Adverse childhood experiences (ACEs), cell-mediated immunity, and survival in the context of cancer.
Brain Behav Immun
; 88: 566-572, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32339603
11.
Dendritic Cell-Based Cancer Vaccines.
J Immunol
; 200(2): 443-449, 2018 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29311386
12.
The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review.
Semin Cancer Biol
; 52(Pt 2): 12-15, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28943324
13.
Interleukin 32 expression in human melanoma.
J Transl Med
; 17(1): 113, 2019 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30953519
14.
First-in-human study of TK-positive oncolytic vaccinia virus delivered by adipose stromal vascular fraction cells.
J Transl Med
; 17(1): 271, 2019 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31426803
15.
Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells.
Cell Immunol
; 335: 59-67, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30392891
16.
Immunotherapy of cancer in 2012.
CA Cancer J Clin
; 62(5): 309-35, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22576456
17.
NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma.
Cancer
; 124(22): 4332-4341, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30303516
18.
Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome.
Cancer Immunol Immunother
; 67(3): 423-434, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29204699
19.
Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma.
J Transl Med
; 16(1): 184, 2018 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29973204
20.
High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation.
Cell Immunol
; 323: 9-18, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217299